APO CL 75
Pill imprint APO CL 75 has been identified as Clopidogrel 75 MG.
Clopidogrel is used in the treatment of heart attack; ischemic stroke; acute coronary syndrome; platelet aggregation inhibition; ischemic stroke, prophylaxis (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy.
Clopidogrel 75 MG is not subject to the Controlled Substances Act.
See also related documents.
Clopidogrel Images
- Imprint:
-
APO
CL 75 - Strength:
- 75 MG
- Color:
- Red
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
crospovidone
methylcellulose
zinc stearate
ferric oxide
hydroxypropyl cellulose
polyethylene glycol 8000
titanium dioxide
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-0253
More CLOPIDOGREL resources
- Clopidogrel (Wolters Kluwer)
- clopidogrel (Cerner Multum)
- clopidogrel (Micromedex) - Includes Dosage Information
- Clopidogrel Bisulfate (AHFS DI)
- Clopidogrel (FDA)
- Clopidogrel (Wolters Kluwer)


